How big is the Global CAR T-Cell Therapy Market?

The Global CAR T-Cell Therapy Market size is expected to reach USD 4.88 billion in 2024 and grow at a CAGR of 18.27% to reach USD 11.30 billion by 2029. Read More

What is the current Global CAR T-Cell Therapy Market size?

In 2024, the Global CAR T-Cell Therapy Market size is expected to reach USD 4.88 billion. Read More

Who are the key players in Global CAR T-Cell Therapy Market?

Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson, Sorrento Therapeutics, Inc. and Gilead Sciences, Inc. (Kite Pharma) are the major companies operating in the Global CAR T-Cell Therapy Market. Read More

Which is the fastest growing region in Global CAR T-Cell Therapy Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global CAR T-Cell Therapy Market?

In 2024, the North America accounts for the largest market share in Global CAR T-Cell Therapy Market. Read More

What years does this Global CAR T-Cell Therapy Market cover, and what was the market size in 2023?

In 2023, the Global CAR T-Cell Therapy Market size was estimated at USD 3.99 billion. The report covers the Global CAR T-Cell Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global CAR T-Cell Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

CAR T-Cell Therapy Market Analysis | Industry Forecast, Size & Report

CAR-T Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global CAR T-Cell Therapy Manufacturers and It is Segmented by Types (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta, and Others), Application (Leukemia, Lymphoma, Multiple Myeloma, and Autoimmune Disorders, and Other Applications), End Users (Hospitals, Cancer Care Treatment Centers) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Report Offers the Value (in USD Million) for the Above Segments.

CAR T-Cell Therapy Industry Overview

The CAR T-Cell therapy market is moderately competitive with several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Novartis AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc. (Kite Pharma), Johnson & Johnson, and Sorrento Therapeutics, Inc., among other players.